Variation in PAH-related DNA adduct levels among non-smokers: The role of multiple genetic polymorphisms and nucleotide excision repair phenotype

International Journal of Cancer

Volumn 132, Issue 12, 2013, Pages 2738-2747

  Etemadi, Arash ^a,b   Islami, Farhad ^b,c,d   Phillips, David H ^e   Godschalk, Roger ^f   Golozar, Asieh ^a,b   Kamangar, Farin ^a,g   Malekshah, Akbar Fazel Tabar ^b   Pourshams, Akram ^b   Elahi, Seerat ^b   Ghojaghi, Farhad ^b   Strickland, Paul T ^h   Taylor, Philip R ^a   Boffetta, Paolo ^d,i   Abnet, Christian C ^a   Dawsey, Sanford M ^a   Malekzadeh, Reza ^b   Van Schooten, Frederik J ^f  

^a NATIONAL CANCER INSTITUTE   (United States)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^e KING'S COLLEGE LONDON   (United Kingdom)

^f MAASTRICHT UNIVERSITY   (Netherlands)

^g MORGAN STATE UNIVERSITY   (United States)

^h JOHNS HOPKINS UNIVERSITY   (United States)

ⁱ INTERNATIONAL PREVENTION RESEARCH INSTITUTE   (France)

Author keywords

DNA adducts; nucleotide excision repair; polycyclic aromatic hydrocarbons; polymorphism

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ARYLAMINE ACETYLTRANSFERASE; MYELOPEROXIDASE; POLYCYCLIC AROMATIC HYDROCARBON;

ADULT; ALLELE; ARTICLE; ARYLAMINE ACETYLTRANSFERASE GENE; COMET ASSAY; DNA ADDUCT; DNA DETERMINATION; ENVIRONMENTAL EXPOSURE; ERCC5 GENE; EXCISION REPAIR; FEMALE; GENE; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; IRAN; METHYLENETETRAHYDROFOLATE REDUCTASE GENE; MYELOPEROXIDASE GENE; PHENOTYPE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ALLELES; COHORT STUDIES; DNA ADDUCTS; DNA REPAIR; FEMALE; GENOTYPE; HUMANS; IRAN; MIDDLE AGED; PHENOTYPE; POLYCYCLIC HYDROCARBONS, AROMATIC; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84876143243     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.27953     Document Type: Article

References (51)

1. Baan R, Grosse Y, Straif K, et al. A review of human carcinogens-Part F: chemical agents and related occupations. Lancet Oncol 2009; 10: 1143-4.
2. Abedi-Ardekani B, Kamangar F, Hewitt SM, et al. Polycyclic aromatic hydrocarbon exposure in oesophageal tissue and risk of oesophageal squamous cell carcinoma in north-eastern Iran. Gut 2010; 59: 1178-83.
3. Kamangar F, Strickland PT, Pourshams A, et al. High exposure to polycyclic aromatic hydrocarbons may contribute to high risk of esophageal cancer in northeastern Iran. Anticancer Res 2005; 25: 425-8.
4. Fagundes RB, Abnet CC, Strickland PT, et al. Higher urine 1-hydroxy pyrene glucuronide (1-OHPG) is associated with tobacco smoke exposure and drinking mate in healthy subjects from Rio Grande do Sul, Brazil. BMC Cancer 2006; 6: 139.
5. Wornat MJ, Ledesma EB, Sandrowitz AK, et al. Polycyclic aromatic hydrocarbons identified in soot extracts from domestic coal-burning stoves of Henan Province, China. Environ Sci Technol 2001; 35: 1943-52.
6. Roth MJ, Qiao YL, Rothman N, et al. High urine 1-hydroxypyrene glucuronide concentrations in Linxian, China, an area of high risk for squamous oesophageal cancer. Biomarkers 2001; 6: 381-6.
7. Roth MJ, Strickland KL, Wang GQ, et al. High levels of carcinogenic polycyclic aromatic hydrocarbons present within food from Linxian, China may contribute to that region's high incidence of oesophageal cancer. Eur J Cancer 1998; 34: 757-8.
8. Hakami R, Mohtadinia J, Etemadi A, et al. Dietary intake of benzo(a)pyrene and risk of esophageal cancer in north of Iran. Nutr Cancer 2008; 60: 216-21.
9. Samet JM, Avila-Tang E, Boffetta P, et al. Lung cancer in never smokers: clinical epidemiology and environmental risk factors. Clin Cancer Res 2009; 15: 5626-45.
10. Godschalk RW, Dallinga JW, Wikman H, et al. Modulation of DNA and protein adducts in smokers by genetic polymorphisms in GSTM1,GSTT1, NAT1 and NAT2. Pharmacogenetics 2001; 11: 389-98.
11. Phillips DH,. DNA adducts as markers of exposure and risk. Mutat Res 2005; 577: 284-92.
12. Ishikawa T, Zhang SS, Qin X, et al. DNA repair and cancer: lessons from mutant mouse models. Cancer Sci 2004; 95: 112-17.
13. Godschalk RW, Van, Schooten FJ, Bartsch H,. A critical evaluation of DNA adducts as biological markers for human exposure to polycyclic aromatic compounds. J Biochem Mol Biol 2003; 36: 1-11.
14. Ketelslegers HB, Gottschalk RW, Godschalk RW, et al. Interindividual variations in DNA adduct levels assessed by analysis of multiple genetic polymorphisms in smokers. Cancer Epidemiol Biomarkers Prev 2006; 15: 624-9.
15. Pourshams A, Khademi H, Malekshah AF, et al. Cohort profile: the Golestan cohort Study-a prospective study of oesophageal cancer in northern Iran. Int J Epidemiol 2010; 39: 52-9.
16. Boyum A,. Isolation of lymphocytes, granulocytes and macrophages. Scand J Immunol 1976; Suppl 5: 9-15.
17. Hirvonen A,. State of the art of genotype vs. phenotype studies. Environmental Cancer Risk, Nutrition and Individual Susceptibility (ECNIS). Lodz: Nofer Institute of Occupational Medicine, 2008. 98 p.
18. Knaapen AM, Ketelslegers HB, Gottschalk RW, et al. Simultaneous genotyping of nine polymorphisms in xenobiotic-metabolizing enzymes by multiplex PCR amplification and single base extension. Clin Chem 2004; 50: 1664-8.
19. Langie SA, Wilms LC, Hamalainen S, et al. Modulation of nucleotide excision repair in human lymphocytes by genetic and dietary factors. Br J Nutr 2010; 103: 490-501.
20. Hansen WK, Kelley MR,. Review of mammalian DNA repair and translational implications. J Pharmacol Exp Ther 2000; 295: 1-9.
21. Langie SA, Knaapen AM, Brauers KJ, et al. Development and validation of a modified comet assay to phenotypically assess nucleotide excision repair. Mutagenesis 2006; 21: 153-8.
22. Redaelli A, Magrassi R, Bonassi S, et al. AP endonuclease activity in humans: development of a simple assay and analysis of ten normal individuals. Teratog Carcinog Mutagen 1998; 18: 17-26.
23. Knaapen AM, Schins RP, Borm PJ, et al. Nitrite enhances neutrophil-induced DNA strand breakage in pulmonary epithelial cells by inhibition of myeloperoxidase. Carcinogenesis 2005; 26: 1642-8.
24. Strickland PT, Kang D, Bowman ED, et al. Identification of 1-hydroxypyrene glucuronide as a major pyrene metabolite in human urine by synchronous fluorescence spectroscopy and gas chromatography-mass spectrometry. Carcinogenesis 1994; 15: 483-7.
25. Phillips DH, Arlt VM,. The 32P-postlabeling assay for DNA adducts. Nat Protoc 2007; 2: 2772-81.
26. Ketelslegers HB, Gottschalk RW, Koppen G, et al. Multiplex genotyping as a biomarker for susceptibility to carcinogenic exposure in the FLEHS biomonitoring study. Cancer Epidemiol Biomarkers Prev 2008; 17: 1902-12.
27. Walker K, Ginsberg G, Hattis D, et al. Genetic polymorphism in N-acetyltransferase (NAT): population distribution of NAT1 and NAT2 activity. J Toxicol Environ Health B Crit Rev 2009; 12: 440-72.
28. Bozdogan H,. Akaike's information criterion and recent developments in information complexity. J Math Psychol 2000; 44: 62-91.
29. Binkova B, Topinka J, Mrackova G, et al. Coke oven workers study: the effect of exposure and GSTM1 and NAT2 genotypes on DNA adduct levels in white blood cells and lymphocytes as determined by 32P-postlabelling. Mutat Res 1998; 416: 67-84.
30. Binkova B, Chvatalova I, Lnenickova Z, et al. PAH-DNA adducts in environmentally exposed population in relation to metabolic and DNA repair gene polymorphisms. Mutat Res 2007; 620: 49-61.
31. Hu Y, Li G, Xue X, et al. PAH-DNA adducts in a Chinese population: relationship to PAH exposure, smoking and polymorphisms of metabolic and DNA repair genes. Biomarkers 2008; 13: 27-40.
32. Phillips DH, Castegnaro M,. Standardization and validation of DNA adduct postlabelling methods: report of interlaboratory trials and production of recommended protocols. Mutagenesis 1999; 14: 301-15.
33. Gallo V, Khan A, Gonzales C, et al. Validation of biomarkers for the study of environmental carcinogens: a review. Biomarkers 2008; 13: 505-34.
34. Brandt HC, Watson WP,. Monitoring human occupational and environmental exposures to polycyclic aromatic compounds. Ann Occup Hyg 2003; 47: 349-78.
35. Burnham KP, Anderson DR,. Model selection and multimodel inference: a practical information-theoretic approach, 2nd edn. New York: Springer, 2002.
36. Alexandrov K, Cascorbi I, Rojas M, et al. CYP1A1 and GSTM1 genotypes affect benzo[a]pyrene DNA adducts in smokers' lung: comparison with aromatic/hydrophobic adduct formation. Carcinogenesis 2002; 23: 1969-77.
37. Butkiewicz D, Grzybowska E, Phillips DH, et al. Polymorphisms of the GSTP1 and GSTM1 genes and PAH-DNA adducts in human mononuclear white blood cells. Environ Mol Mutagen 2000; 35: 99-105.
38. Georgiadis P, Demopoulos NA, Topinka J, et al. Impact of phase I or phase II enzyme polymorphisms on lymphocyte DNA adducts in subjects exposed to urban air pollution and environmental tobacco smoke. Toxicol Lett 2004; 149: 269-80.
39. Agudo A, Peluso M, Sala N, et al. Aromatic DNA adducts and polymorphisms in metabolic genes in healthy adults: findings from the EPIC-Spain cohort. Carcinogenesis 2009; 30: 968-76.
40. Abnet CC, Fagundes RB, Strickland PT, et al. The influence of genetic polymorphisms in Ahr, CYP1A1, CYP1A2, CYP1B1, GST M1, GST T1 and UGT1A1 on urine 1-hydroxypyrene glucuronide concentrations in healthy subjects from Rio Grande do Sul, Brazil. Carcinogenesis 2007; 28: 112-17.
41. Petruska JM, Mosebrook DR, Jakab GJ, et al. Myeloperoxidase-enhanced formation of (+-)-trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene-DNA adducts in lung tissue in vitro: a role of pulmonary inflammation in the bioactivation of a procarcinogen. Carcinogenesis 1992; 13: 1075-81.
42. Knaapen AM, Gungor N, Schins RP, et al. Neutrophils and respiratory tract DNA damage and mutagenesis: a review. Mutagenesis 2006; 21: 225-36.
43. Gungor N, Godschalk RW, Pachen DM, et al. Activated neutrophils inhibit nucleotide excision repair in human pulmonary epithelial cells: role of myeloperoxidase. FASEB J 2007; 21: 2359-67.
44. Gungor N, Haegens A, Knaapen AM, et al. Lung inflammation is associated with reduced pulmonary nucleotide excision repair in vivo. Mutagenesis 2010; 25: 77-82.
45. Rojas M, Godschalk R, Alexandrov K, et al. Myeloperoxidase-463A variant reduces benzo[a]pyrene diol epoxide DNA adducts in skin of coal tar treated patients. Carcinogenesis 2001; 22: 1015-18.
46. Van Schooten FJ, Boots AW, Knaapen AM, et al. Myeloperoxidase (MPO) -463G->A reduces MPO activity and DNA adduct levels in bronchoalveolar lavages of smokers. Cancer Epidemiol Biomarkers Prev 2004; 13: 828-33.
47. Lee MS, Su L, Christiani DC,. Synergistic effects of NAT2 slow and GSTM1 null genotypes on carcinogen DNA damage in the lung. Cancer Epidemiol Biomarkers Prev 2010; 19: 1492-7.
48. Kiyohara C, Yoshimasu K,. Genetic polymorphisms in the nucleotide excision repair pathway and lung cancer risk: a meta-analysis. Int J Med Sci 2007; 4: 59-71.
49. Lee MS, Su L, Mark EJ, et al. Genetic modifiers of carcinogen DNA adducts in target lung and peripheral blood mononuclear cells. Carcinogenesis 2010; 31: 2091-6.
50. Ma J, Stampfer MJ, Giovannucci E, et al. Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer. Cancer Res 1997; 57: 1098-102.
51. Choi SW, Kim YI, Weitzel JN, et al. Folate depletion impairs DNA excision repair in the colon of the rat. Gut 1998; 43: 93-9.